Previous 10 | Next 10 |
Ampio Pharmaceuticals (AMPE) has launched a global clinical trial for the IV formulation of its lead asset Ampion for treating COVID-19 patients including in out-patient settings. It has also provided updates on Phase I clinical trial for the inhaled formulation of the Ampion curren...
Ampio Provides Update on Clinical Trials for Ampion™ Treatment of COVID-19 Patients PR Newswire ENGLEWOOD, Colo. , Jan. 4, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancem...
Strong SACCOVID clinical trial results suggest an approval is forthcoming. Graft versus Host Disease linkage to the most promising therapeutics. Merck business model resonating with investors. Small pool of therapeutic drug companies represents ideal acquisition targets. ...
These 3 Penny Stocks Were Trending On December 31 st ; Can That Continue? As New Year’s Eve comes and goes, a new year for penny stocks is upon us. In 2021, there are several factors that could change the trajectory of certain stocks. As investors, we always have to think...
Gainers: Hoth Therapeutics (HOTH) +49%. Bionano Genomics (BNGO) +38%. Clearside Biomedical (CLSD) +17%. Regional Health Properties (RHE) +14%. Ampio Pharmaceuticals (AMPE) +13%.Losers: Histogen (HSTO) -26%. Novan (NOVN) -22%. ORIC Pharmaceuticals (ORIC) -14%. DermTech (DMTK) -12%. T...
Ashford (AINC) +75%.PEDEVCO (PED) +62%.SGOCO (SGOC) +49%.Ebang International Holdings (EBON) +33%.Red Lion Hotels RLH +31% on being acquired by Sonesta.Canaan (CAN) +30%.AirNet Technology (ANTE) +25%.Hudson Capital HUSN +24% as FreightHub posts stellar Q3 results.Hoth Ther...
Gainers: Bionano Genomics (BNGO) +82%, DermTech (DMTK) +25%, IMAC Holdings (IMAC) +20%, Gritstone Oncology (GRTS) +15%, Hepion Pharmaceuticals (HEPA) +12%.Losers: Regional Health Properties (RHE) -20%, Osmotica Pharmaceuticals (OSMT) -20%, Equ...
Shares of Ampio Pharmaceuticals (NYSEMKT: AMPE) were tanking by 18.6% as of 3:42 p.m. EST on Tuesday. The big drop came after the company announced that it had received feedback from the U.S. Food and Drug Administration (FDA) on proposed modifications to the special protocol assess...
Ampio Pharmaceuticals (AMPE) says it has received guidance from the FDA regarding the impact of COVID-19 on its Phase III clinical trial for osteoarthritis of the knee ("OAK").Conducted under a Special Protocol Assessment, the late-stage trial involved the intra-articular injection ...
Ampio Receives feedback from the FDA on Ampio's Proposed Modifications to the special protocol assessment for Ampion treatment of severe Osteoarthritis of the knee PR Newswire ENGLEWOOD, Colo. , Dec. 29, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE Amer...
News, Short Squeeze, Breakout and More Instantly...
Ampio Pharmaceuticals Inc. Company Name:
AMPE Stock Symbol:
OTCMKTS Market:
Ampio Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Next.e.GO N.V. (EGOX) rose 94.4% to $0.07 on volume of 92,836,985 shares AGBA Group Holding Limited (AGBA) rose 46.1% to $1.505 on volume of 55,502,222 shares PROSHARES TRUST (SQQQ) rose 1.2% to $12.2099 on volume of 25,933,897 shares...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 7.2% to $0.04 on volume of 426,309,096 shares PROSHARES TRUST (SQQQ) rose 1.8% to $12.07 on volume of 171,048,374 shares AGBA Group Holding Limited (AGBA) rose 157.5% to $1.03 on volume of 121,894,6...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...